(NASDAQ: KOD) Kodiak Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.48%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.99%.
Kodiak Sciences's earnings in 2026 is -$230,664,000.On average, 7 Wall Street analysts forecast KOD's earnings for 2026 to be -$236,490,186, with the lowest KOD earnings forecast at -$247,147,295, and the highest KOD earnings forecast at -$228,661,623. On average, 6 Wall Street analysts forecast KOD's earnings for 2027 to be -$197,072,026, with the lowest KOD earnings forecast at -$214,644,053, and the highest KOD earnings forecast at -$189,894,279.
In 2028, KOD is forecast to generate -$54,142,867 in earnings, with the lowest earnings forecast at -$106,708,758 and the highest earnings forecast at -$25,625,872.